Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1987;23(Suppl 1):43S–50S. doi: 10.1111/j.1365-2125.1987.tb03121.x

Captopril and hydrochlorothiazide

Rationale for their combination

E Ambrosioni, C Borghi, F V Costa
PMCID: PMC1386045  PMID: 3555583

Abstract

1 The result of controlled clinical studies have shown that about 80% of hypertensive patients have a satisfactory blood pressure reduction when treated with a combination of captopril and thiazide diuretics. The high response rate to this treatment can be explained on the basis of the mechanism of action of these drugs. In the long term, diuretics act by reducing peripheral vascular resistance. The mechanism by which they reduce peripheral vascular resistance is the subject of debate, but could be explained on the basis of cellular ionic changes.

2 From our studies, it was observed that thiazides cause a reduction in intracellular Na+ (Nai) and in intra- and extracellular K+ (Ki, Ke). Since in many patients Ke losses are greater than Ki losses, the Ki/Ke ratio (which is directly related to membrane potential and thus to vascular tone) increases. Captopril also reduces Nai, but its effects on Ke and Ki are quite different from those of thiazides. Captopril in fact causes an increase in Ki inducing a net increase in Ki/Ke. This increase can also be observed when captopril is given in combination with thiazides.

3 Therefore the combination of captopril and thiazides has an additive effect on Nai, and increases Ki/Ke in the vast majority of patients. The decrease in Nai probably acts by reducing membrane sensitivity to catecholamines and angiotensin, whereas the increase in Ki/Ke acts by hyperpolarizing vascular smooth muscle membrane. The combination of captopril and thiazides also has favourable metabolic effects.

4 In a 2 year study, we observed that the captopril-thiazide combination does not produce any of the unwanted metabolic effects which can be observed by administering thiazides alone, and that cholesterol is significantly reduced in those subjects having pre-treatment values greater than 20% above normal.

Keywords: captopril, hydrochlorothiazide, hypertension, sodium, potassium

Full text

PDF
43S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambrosioni E., Costa F. V., Borghi C., Mussi A., Boschi S. Modifications of intra- and extracellular sodium and potassium. A possible mechanism for the antihypertensive action of captopril and hydrochlorothiazide. J Hypertens Suppl. 1985 Dec;3(3):S69–S71. [PubMed] [Google Scholar]
  2. Ambrosioni E., Costa F. V., Borghi C., Mussi A. Influence of captopril on intracellular ions--a possible mode of action. Postgrad Med J. 1986;62 (Suppl 1):16–22. [PubMed] [Google Scholar]
  3. Blaustein M. P. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol. 1977 May;232(5):C165–C173. doi: 10.1152/ajpcell.1977.232.5.C165. [DOI] [PubMed] [Google Scholar]
  4. Burks T. F., Spalding C. T., Jones V. D. Influence of sodium and potassium content on arterial responsiveness. Circ Res. 1971 Nov;29(5):525–533. doi: 10.1161/01.res.29.5.525. [DOI] [PubMed] [Google Scholar]
  5. Costa F. V., Borghi C., Ambrosioni E. Captopril and oxprenolol in a fixed combination with thiazide diuretics: comparison of their antihypertensive efficacy and metabolic effects. Clin Ther. 1984;6(5):708–718. [PubMed] [Google Scholar]
  6. Costa F. V., Borghi C., Boschi S., Ambrosioni E. Differing dosages of captopril and hydrochlorothiazide in the treatment of hypertension: long-term effects metabolic values and intracellular electrolytes. J Cardiovasc Pharmacol. 1985;7 (Suppl 1):S70–S76. doi: 10.1097/00005344-198507001-00014. [DOI] [PubMed] [Google Scholar]
  7. Costa F. V., Borghi C., Mussi A., Ambrosioni E. Antihypertensive efficacy of two low dosages of hydrochlorothiazide in patients treated with captopril. Clin Ther. 1985;7(6):717–724. [PubMed] [Google Scholar]
  8. Johnston C. I., Arnolda L., Hiwatari M. Angiotensin-converting enzyme inhibitors in the treatment of hypertension. Drugs. 1984 Mar;27(3):271–277. doi: 10.2165/00003495-198427030-00006. [DOI] [PubMed] [Google Scholar]
  9. Lederle R. M. Captopril and hydrochlorothiazide in the fixed combination multicenter trial. J Cardiovasc Pharmacol. 1985;7 (Suppl 1):S63–S69. doi: 10.1097/00005344-198507001-00013. [DOI] [PubMed] [Google Scholar]
  10. Leonetti G., Terzoli L., Sala C., Bianchini C., Sernesi L., Zanchetti A. Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients. Clin Sci Mol Med Suppl. 1978 Dec;4:307s–309s. doi: 10.1042/cs055307s. [DOI] [PubMed] [Google Scholar]
  11. Tobian L., Olson R., Chesley G. Water content of arteriolar wall in renovascular hypertension. Am J Physiol. 1969 Jan;216(1):22–24. doi: 10.1152/ajplegacy.1969.216.1.22. [DOI] [PubMed] [Google Scholar]
  12. Weber M. A., Drayer J. I., Rev A., Laragh J. H. Disparate patterns of aldosterone response during diuretic treatment of hypertension. Ann Intern Med. 1977 Nov;87(5):558–563. doi: 10.7326/0003-4819-87-5-558. [DOI] [PubMed] [Google Scholar]
  13. Weinberger M. H. Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients. J Cardiovasc Pharmacol. 1985;7 (Suppl 1):S52–S55. doi: 10.1097/00005344-198507001-00011. [DOI] [PubMed] [Google Scholar]
  14. van Brummelen P., Man in 't Veld A. J., Schalekamp M. A. Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and nonresponders. Clin Pharmacol Ther. 1980 Mar;27(3):328–336. doi: 10.1038/clpt.1980.44. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES